Feng Cheng

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Cell Proliferation

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Science advances

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Lawrence Huang, Feng Cheng, Xuetao Zhang, Jacek Zielonka, Matthew A Nystoriak, Weiwei Xiang, Kunal P Raygor, Shaoxun Wang, Aditya Lakshmanan, Weiya Jiang, Sai Yuan, Kevin S Hou, Jiayi Zhang, Xitao Wang, Arsalan U Syed, Matea Juric, Takamune Takahashi, Manuel F Navedo, Rong A Wang
Nitric oxide synthase and reduced arterial tone contribute to arteriovenous malformation. Science advances 9 (21) (2023)
Yang Yu, Wen-Ming Cao, Feng Cheng, Zhongcheng Shi, Lili Han, Jin-Ling Yi, Edaise M da Silva, Higinio Dopeso, Hui Chen, Jianhua Yang, Xiaosong Wang, Chunchao Zhang, Hong Zhang
FOXK2 amplification and overexpression promotes breast cancer development and chemoresistance. bioRxiv : the preprint server for biology (2023)
Yang Yu, Yanling Zhao, Jong Min Choi, Zhongcheng Shi, Linjie Guo, John Elizarraras, Andy Gu, Feng Cheng, Yanxin Pei, Dai Lu, Muller Fabbri, Saurabh Agarwal, Chunchao Zhang, Sung Yun Jung, Jennifer H Foster, Jianhua Yang
ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo. Cancers 14 (22) (2022)